Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: A potential new approach for the treatment of hyperinsulinemic hypoglycemia
mAbs 6:1, 262–272; January/February 2014; © 2014 Landes Bioscience
In the study of congenital hyperinsulinism now enrolling phase III sunRIZE trial
